Did you know ? If you order before Friday 14h we deliver 90PCT of the the time next Tuesday, GENTAUR another in time delivery

Mitogen-activated protein kinase 14 (MAP kinase 14) (MAPK 14) (EC 2.7.11.24) (Mitogen-activated protein kinase p38 alpha) (MAP kinase p38 alpha)

 MK14_CANLF              Reviewed;         360 AA.
O02812;
15-JUL-1998, integrated into UniProtKB/Swiss-Prot.
23-JAN-2007, sequence version 3.
30-AUG-2017, entry version 148.
RecName: Full=Mitogen-activated protein kinase 14;
Short=MAP kinase 14;
Short=MAPK 14;
EC=2.7.11.24 {ECO:0000250|UniProtKB:Q16539};
AltName: Full=Mitogen-activated protein kinase p38 alpha;
Short=MAP kinase p38 alpha;
Name=MAPK14; Synonyms=CSBP1, CSBP2;
Canis lupus familiaris (Dog) (Canis familiaris).
Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
Mammalia; Eutheria; Laurasiatheria; Carnivora; Caniformia; Canidae;
Canis.
NCBI_TaxID=9615;
[1]
NUCLEOTIDE SEQUENCE [MRNA].
TISSUE=Smooth muscle;
PubMed=9688607;
Hedges J.C., Yamboliev I.A., Ngo M., Horowitz B., Adam L.P.,
Gerthoffer W.T.;
"p38 mitogen-activated protein kinase expression and activation in
smooth muscle.";
Am. J. Physiol. 275:C527-C534(1998).
-!- FUNCTION: Serine/threonine kinase which acts as an essential
component of the MAP kinase signal transduction pathway. MAPK14 is
one of the four p38 MAPKs which play an important role in the
cascades of cellular responses evoked by extracellular stimuli
such as proinflammatory cytokines or physical stress leading to
direct activation of transcription factors. Accordingly, p38 MAPKs
phosphorylate a broad range of proteins and it has been estimated
that they may have approximately 200 to 300 substrates each. Some
of the targets are downstream kinases which are activated through
phosphorylation and further phosphorylate additional targets.
RPS6KA5/MSK1 and RPS6KA4/MSK2 can directly phosphorylate and
activate transcription factors such as CREB1, ATF1, the NF-kappa-B
isoform RELA/NFKB3, STAT1 and STAT3, but can also phosphorylate
histone H3 and the nucleosomal protein HMGN1. RPS6KA5/MSK1 and
RPS6KA4/MSK2 play important roles in the rapid induction of
immediate-early genes in response to stress or mitogenic stimuli,
either by inducing chromatin remodeling or by recruiting the
transcription machinery. On the other hand, two other kinase
targets, MAPKAPK2/MK2 and MAPKAPK3/MK3, participate in the control
of gene expression mostly at the post-transcriptional level, by
phosphorylating ZFP36 (tristetraprolin) and ELAVL1, and by
regulating EEF2K, which is important for the elongation of mRNA
during translation. MKNK1/MNK1 and MKNK2/MNK2, two other kinases
activated by p38 MAPKs, regulate protein synthesis by
phosphorylating the initiation factor EIF4E2. MAPK14 interacts
also with casein kinase II, leading to its activation through
autophosphorylation and further phosphorylation of TP53/p53. In
the cytoplasm, the p38 MAPK pathway is an important regulator of
protein turnover. For example, CFLAR is an inhibitor of TNF-
induced apoptosis whose proteasome-mediated degradation is
regulated by p38 MAPK phosphorylation. In a similar way, MAPK14
phosphorylates the ubiquitin ligase SIAH2, regulating its activity
towards EGLN3. MAPK14 may also inhibit the lysosomal degradation
pathway of autophagy by interfering with the intracellular
trafficking of the transmembrane protein ATG9. Another function of
MAPK14 is to regulate the endocytosis of membrane receptors by
different mechanisms that impinge on the small GTPase RAB5A. In
addition, clathrin-mediated EGFR internalization induced by
inflammatory cytokines and UV irradiation depends on MAPK14-
mediated phosphorylation of EGFR itself as well as of RAB5A
effectors. Ectodomain shedding of transmembrane proteins is
regulated by p38 MAPKs as well. In response to inflammatory
stimuli, p38 MAPKs phosphorylate the membrane-associated
metalloprotease ADAM17. Such phosphorylation is required for
ADAM17-mediated ectodomain shedding of TGF-alpha family ligands,
which results in the activation of EGFR signaling and cell
proliferation. Another p38 MAPK substrate is FGFR1. FGFR1 can be
translocated from the extracellular space into the cytosol and
nucleus of target cells, and regulates processes such as rRNA
synthesis and cell growth. FGFR1 translocation requires p38 MAPK
activation. In the nucleus, many transcription factors are
phosphorylated and activated by p38 MAPKs in response to different
stimuli. Classical examples include ATF1, ATF2, ATF6, ELK1, PTPRH,
DDIT3, TP53/p53 and MEF2C and MEF2A. The p38 MAPKs are emerging as
important modulators of gene expression by regulating chromatin
modifiers and remodelers. The promoters of several genes involved
in the inflammatory response, such as IL6, IL8 and IL12B, display
a p38 MAPK-dependent enrichment of histone H3 phosphorylation on
'Ser-10' (H3S10ph) in LPS-stimulated myeloid cells. This
phosphorylation enhances the accessibility of the cryptic NF-
kappa-B-binding sites marking promoters for increased NF-kappa-B
recruitment. Phosphorylates CDC25B and CDC25C which is required
for binding to 14-3-3 proteins and leads to initiation of a G2
delay after ultraviolet radiation. Phosphorylates TIAR following
DNA damage, releasing TIAR from GADD45A mRNA and preventing mRNA
degradation. The p38 MAPKs may also have kinase-independent roles,
which are thought to be due to the binding to targets in the
absence of phosphorylation. Protein O-Glc-N-acylation catalyzed by
the OGT is regulated by MAPK14, and, although OGT does not seem to
be phosphorylated by MAPK14, their interaction increases upon
MAPK14 activation induced by glucose deprivation. This interaction
may regulate OGT activity by recruiting it to specific targets
such as neurofilament H, stimulating its O-Glc-N-acylation.
Required in mid-fetal development for the growth of embryo-derived
blood vessels in the labyrinth layer of the placenta. Also plays
an essential role in developmental and stress-induced
erythropoiesis, through regulation of EPO gene expression (By
similarity). Phosphorylates S100A9 at 'Thr-113' (By similarity).
{ECO:0000250|UniProtKB:Q16539}.
-!- CATALYTIC ACTIVITY: ATP + a protein = ADP + a phosphoprotein.
{ECO:0000250|UniProtKB:Q16539}.
-!- COFACTOR:
Name=Mg(2+); Xref=ChEBI:CHEBI:18420;
Evidence={ECO:0000250|UniProtKB:Q16539};
-!- ENZYME REGULATION: Activated by cell stresses such as DNA damage,
heat shock, osmotic shock, anisomycin and sodium arsenite, as well
as pro-inflammatory stimuli such as bacterial lipopolysaccharide
(LPS) and interleukin-1. Activation occurs through dual
phosphorylation of Thr-180 and Tyr-182 by either of two dual
specificity kinases, MAP2K3/MKK3 or MAP2K6/MKK6, and potentially
also MAP2K4/MKK4, as well as by TAB1-mediated autophosphorylation.
MAPK14 phosphorylated on both Thr-180 and Tyr-182 is 10-20-fold
more active than MAPK14 phosphorylated only on Thr-180, whereas
MAPK14 phosphorylated on Tyr-182 alone is inactive. whereas Thr-
180 is necessary for catalysis, Tyr-182 may be required for auto-
activation and substrate recognition. Phosphorylated at Tyr-323 by
ZAP70 in an alternative activation pathway in response to TCR
signaling in T-cells. This alternative pathway is inhibited by
GADD45A. Inhibited by dual specificity phosphatases, such as
DUSP1, DUSP10, and DUSP16. Specifically inhibited by the binding
of pyridinyl-imidazole compounds, which are cytokine-suppressive
anti-inflammatory drugs (CSAID). SB203580 is an inhibitor of
MAPK14 (By similarity). {ECO:0000250|UniProtKB:Q16539}.
-!- SUBUNIT: Component of a signaling complex containing at least
AKAP13, PKN1, MAPK14, ZAK and MAP2K3. Within this complex, AKAP13
interacts directly with PKN1, which in turn recruits MAPK14,
MAP2K3 and ZAK (By similarity). Binds to a kinase interaction
motif within the protein tyrosine phosphatase, PTPRR (By
similarity). This interaction retains MAPK14 in the cytoplasm and
prevents nuclear accumulation (By similarity). Interacts with
SPAG9 and GADD45A (By similarity). Interacts with CDC25B, CDC25C,
DUSP1, DUSP10, DUSP16, NP60, SUPT20H and TAB1. Interacts with
casein kinase II subunits CSNK2A1 and CSNK2B. Interacts with
PPM1D. Interacts with CDK5RAP3; recruits PPM1D to MAPK14 and may
regulate its dephosphorylation (By similarity). {ECO:0000250,
ECO:0000250|UniProtKB:P47811, ECO:0000250|UniProtKB:Q16539}.
-!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000250|UniProtKB:Q16539}.
Nucleus {ECO:0000250|UniProtKB:Q16539}.
-!- DOMAIN: The TXY motif contains the threonine and tyrosine residues
whose phosphorylation activates the MAP kinases.
-!- PTM: Dually phosphorylated on Thr-180 and Tyr-182 by the MAP2Ks
MAP2K3/MKK3, MAP2K4/MKK4 and MAP2K6/MKK6 in response to
inflammatory citokines, environmental stress or growth factors,
which activates the enzyme. Dual phosphorylation can also be
mediated by TAB1-mediated autophosphorylation. TCR engagement in
T-cells also leads to Tyr-323 phosphorylation by ZAP70.
Dephosphorylated and inactivated by DUPS1, DUSP10 and DUSP16 (By
similarity). PPM1D also mediates dephosphorylation and
inactivation of MAPK14 (By similarity). {ECO:0000250,
ECO:0000250|UniProtKB:Q16539}.
-!- PTM: Acetylated at Lys-53 and Lys-152 by KAT2B and EP300.
Acetylation at Lys-53 increases the affinity for ATP and enhances
kinase activity. Lys-53 and Lys-152 are deacetylated by HDAC3 (By
similarity). {ECO:0000250|UniProtKB:Q16539}.
-!- PTM: Ubiquitinated. Ubiquitination leads to degradation by the
proteasome pathway (By similarity).
{ECO:0000250|UniProtKB:Q16539}.
-!- SIMILARITY: Belongs to the protein kinase superfamily. CMGC
Ser/Thr protein kinase family. MAP kinase subfamily.
{ECO:0000305}.
-----------------------------------------------------------------------
Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
Distributed under the Creative Commons Attribution-NoDerivs License
-----------------------------------------------------------------------
EMBL; AF003597; AAC36131.1; -; mRNA.
RefSeq; NP_001003206.1; NM_001003206.1.
UniGene; Cfa.2823; -.
ProteinModelPortal; O02812; -.
SMR; O02812; -.
STRING; 9615.ENSCAFP00000001968; -.
PaxDb; O02812; -.
PRIDE; O02812; -.
Ensembl; ENSCAFT00000002127; ENSCAFP00000001968; ENSCAFG00000001378.
GeneID; 403856; -.
KEGG; cfa:403856; -.
CTD; 1432; -.
eggNOG; KOG0660; Eukaryota.
eggNOG; ENOG410XNY0; LUCA.
GeneTree; ENSGT00550000074271; -.
HOGENOM; HOG000233024; -.
HOVERGEN; HBG014652; -.
InParanoid; O02812; -.
KO; K04441; -.
OMA; EQFQQVY; -.
OrthoDB; EOG091G08QL; -.
TreeFam; TF105100; -.
Reactome; R-CFA-171007; p38MAPK events.
Reactome; R-CFA-198753; ERK/MAPK targets.
Reactome; R-CFA-2559580; Oxidative Stress Induced Senescence.
Reactome; R-CFA-375170; CDO in myogenesis.
Reactome; R-CFA-376172; DSCAM interactions.
Reactome; R-CFA-418592; ADP signalling through P2Y purinoceptor 1.
Reactome; R-CFA-432142; Platelet sensitization by LDL.
Reactome; R-CFA-4420097; VEGFA-VEGFR2 Pathway.
Reactome; R-CFA-450302; activated TAK1 mediates p38 MAPK activation.
Reactome; R-CFA-450341; Activation of the AP-1 family of transcription factors.
Reactome; R-CFA-6798695; Neutrophil degranulation.
Reactome; R-CFA-6804756; Regulation of TP53 Activity through Phosphorylation.
Proteomes; UP000002254; Chromosome 12.
Bgee; ENSCAFG00000001378; -.
GO; GO:0005737; C:cytoplasm; ISS:UniProtKB.
GO; GO:0005829; C:cytosol; IEA:Ensembl.
GO; GO:0070062; C:extracellular exosome; IEA:Ensembl.
GO; GO:0005739; C:mitochondrion; IEA:Ensembl.
GO; GO:0016607; C:nuclear speck; IEA:Ensembl.
GO; GO:0005634; C:nucleus; ISS:UniProtKB.
GO; GO:0000922; C:spindle pole; IEA:Ensembl.
GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
GO; GO:0004707; F:MAP kinase activity; ISS:UniProtKB.
GO; GO:0048273; F:mitogen-activated protein kinase p38 binding; IEA:Ensembl.
GO; GO:0051525; F:NFAT protein binding; IEA:Ensembl.
GO; GO:0019903; F:protein phosphatase binding; IEA:Ensembl.
GO; GO:0001525; P:angiogenesis; IEA:Ensembl.
GO; GO:0006915; P:apoptotic process; IEA:UniProtKB-KW.
GO; GO:0001502; P:cartilage condensation; IEA:Ensembl.
GO; GO:0000902; P:cell morphogenesis; IEA:Ensembl.
GO; GO:0048870; P:cell motility; TAS:AgBase.
GO; GO:0071479; P:cellular response to ionizing radiation; IEA:Ensembl.
GO; GO:0071223; P:cellular response to lipoteichoic acid; IEA:Ensembl.
GO; GO:0035924; P:cellular response to vascular endothelial growth factor stimulus; IEA:Ensembl.
GO; GO:0098586; P:cellular response to virus; IEA:Ensembl.
GO; GO:0002062; P:chondrocyte differentiation; IEA:Ensembl.
GO; GO:0000077; P:DNA damage checkpoint; IEA:Ensembl.
GO; GO:0019395; P:fatty acid oxidation; IEA:Ensembl.
GO; GO:0006006; P:glucose metabolic process; IEA:Ensembl.
GO; GO:0035556; P:intracellular signal transduction; ISS:UniProtKB.
GO; GO:0031663; P:lipopolysaccharide-mediated signaling pathway; IEA:Ensembl.
GO; GO:0014835; P:myoblast differentiation involved in skeletal muscle regeneration; IEA:Ensembl.
GO; GO:0090090; P:negative regulation of canonical Wnt signaling pathway; IEA:Ensembl.
GO; GO:0030316; P:osteoclast differentiation; IEA:Ensembl.
GO; GO:0038066; P:p38MAPK cascade; ISS:UniProtKB.
GO; GO:0018105; P:peptidyl-serine phosphorylation; IEA:Ensembl.
GO; GO:0016310; P:phosphorylation; IDA:AgBase.
GO; GO:0001890; P:placenta development; IEA:Ensembl.
GO; GO:0090336; P:positive regulation of brown fat cell differentiation; IEA:Ensembl.
GO; GO:0060045; P:positive regulation of cardiac muscle cell proliferation; IEA:Ensembl.
GO; GO:0031281; P:positive regulation of cyclase activity; IEA:Ensembl.
GO; GO:0002741; P:positive regulation of cytokine secretion involved in immune response; IEA:Ensembl.
GO; GO:0045648; P:positive regulation of erythrocyte differentiation; IEA:Ensembl.
GO; GO:0046326; P:positive regulation of glucose import; IEA:Ensembl.
GO; GO:2001184; P:positive regulation of interleukin-12 secretion; IEA:Ensembl.
GO; GO:0010759; P:positive regulation of macrophage chemotaxis; IEA:Ensembl.
GO; GO:1905050; P:positive regulation of metallopeptidase activity; IEA:Ensembl.
GO; GO:0045663; P:positive regulation of myoblast differentiation; ISS:UniProtKB.
GO; GO:1901741; P:positive regulation of myoblast fusion; ISS:UniProtKB.
GO; GO:0010831; P:positive regulation of myotube differentiation; ISS:UniProtKB.
GO; GO:0042327; P:positive regulation of phosphorylation; NAS:AgBase.
GO; GO:0042307; P:positive regulation of protein import into nucleus; IEA:Ensembl.
GO; GO:2000379; P:positive regulation of reactive oxygen species metabolic process; IEA:Ensembl.
GO; GO:0051091; P:positive regulation of sequence-specific DNA binding transcription factor activity; TAS:AgBase.
GO; GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IEA:Ensembl.
GO; GO:1900015; P:regulation of cytokine production involved in inflammatory response; IEA:Ensembl.
GO; GO:0030278; P:regulation of ossification; IEA:Ensembl.
GO; GO:0006357; P:regulation of transcription from RNA polymerase II promoter; ISS:UniProtKB.
GO; GO:0032495; P:response to muramyl dipeptide; IEA:Ensembl.
GO; GO:0035994; P:response to muscle stretch; IEA:Ensembl.
GO; GO:0042770; P:signal transduction in response to DNA damage; IEA:Ensembl.
GO; GO:0007519; P:skeletal muscle tissue development; IEA:Ensembl.
GO; GO:0006939; P:smooth muscle contraction; TAS:AgBase.
GO; GO:0090400; P:stress-induced premature senescence; IEA:Ensembl.
GO; GO:0051146; P:striated muscle cell differentiation; IEA:Ensembl.
GO; GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW.
GO; GO:0007178; P:transmembrane receptor protein serine/threonine kinase signaling pathway; IEA:Ensembl.
GO; GO:0048010; P:vascular endothelial growth factor receptor signaling pathway; IEA:Ensembl.
InterPro; IPR011009; Kinase-like_dom.
InterPro; IPR003527; MAP_kinase_CS.
InterPro; IPR008352; MAPK_p38.
InterPro; IPR000719; Prot_kinase_dom.
InterPro; IPR017441; Protein_kinase_ATP_BS.
Pfam; PF00069; Pkinase; 1.
PRINTS; PR01773; P38MAPKINASE.
SMART; SM00220; S_TKc; 1.
SUPFAM; SSF56112; SSF56112; 1.
PROSITE; PS01351; MAPK; 1.
PROSITE; PS00107; PROTEIN_KINASE_ATP; 1.
PROSITE; PS50011; PROTEIN_KINASE_DOM; 1.
2: Evidence at transcript level;
Acetylation; Apoptosis; ATP-binding; Complete proteome; Cytoplasm;
Kinase; Nucleotide-binding; Nucleus; Phosphoprotein;
Reference proteome; Serine/threonine-protein kinase; Stress response;
Transcription; Transcription regulation; Transferase; Ubl conjugation.
INIT_MET 1 1 Removed. {ECO:0000250|UniProtKB:Q16539}.
CHAIN 2 360 Mitogen-activated protein kinase 14.
/FTId=PRO_0000186290.
DOMAIN 24 308 Protein kinase. {ECO:0000255|PROSITE-
ProRule:PRU00159}.
NP_BIND 30 38 ATP. {ECO:0000255|PROSITE-
ProRule:PRU00159}.
MOTIF 180 182 TXY.
ACT_SITE 150 150 Proton acceptor. {ECO:0000255|PROSITE-
ProRule:PRU00159}.
BINDING 53 53 ATP. {ECO:0000255|PROSITE-
ProRule:PRU00159}.
MOD_RES 2 2 N-acetylserine.
{ECO:0000250|UniProtKB:Q16539}.
MOD_RES 2 2 Phosphoserine.
{ECO:0000250|UniProtKB:Q16539}.
MOD_RES 16 16 Phosphothreonine.
{ECO:0000250|UniProtKB:Q16539}.
MOD_RES 53 53 N6-acetyllysine.
{ECO:0000250|UniProtKB:Q16539}.
MOD_RES 152 152 N6-acetyllysine.
{ECO:0000250|UniProtKB:Q16539}.
MOD_RES 180 180 Phosphothreonine; by MAP2K3, MAP2K4,
MAP2K6 and autocatalysis.
{ECO:0000250|UniProtKB:Q16539}.
MOD_RES 182 182 Phosphotyrosine; by MAP2K3, MAP2K4,
MAP2K6 and autocatalysis.
{ECO:0000250|UniProtKB:Q16539}.
MOD_RES 263 263 Phosphothreonine.
{ECO:0000250|UniProtKB:Q16539}.
MOD_RES 323 323 Phosphotyrosine; by ZAP70.
{ECO:0000250|UniProtKB:Q16539}.
SEQUENCE 360 AA; 41265 MW; 786D81D08F6BB6CB CRC64;
MSQERPTFYR QELNKTIWEV PERYQNLSPV GSGAYGSVCA AFDTKTGLRV AVKKLSRPFQ
SIIHAKRTYR ELRLLKHMKH ENVIGLLDVF TPARSLEEFN DVYLVTHLMG ADLNNIVKCQ
KLTDDHVQFL IYQILRGLKY IHSADIIHRD LKPSNLAVNE DCELKILDFG LARHTDDEMT
GYVATRWYRA PEIMLNWMHY NQTVDIWSVG CIMAELLTGR TLFPGTDHID QLKLILRLVG
TPGADLLKKI SSESARNYIQ SLTQMPKMNF ANVFIGANPL AVDLLEKMLV LDSDKRITAA
QALAHAYFAQ YHDPDDEPVA DPYDQSFESR DLLIDEWKSL TYDEVVSFVP PPLDQEEMES


Related products :

Catalog number Product name Quantity
EIAAB24874 CRK1,Csbp1,Csbp2,MAP kinase 14,MAP kinase p38 alpha,MAPK 14,Mapk14,Mitogen-activated protein kinase 14,Mitogen-activated protein kinase p38 alpha,Rat,Rattus norvegicus
E1206m ELISA kit Erk2,ERK-2,ERT1,Extracellular signal-regulated kinase 2,MAP kinase 1,MAP kinase 2,MAP kinase isoform p42,Mapk,MAPK 1,MAPK 2,Mapk1,Mitogen-activated protein kinase 1,Mitogen-activated protei 96T
E1206r ELISA kit Erk2,ERK-2,ERT1,Extracellular signal-regulated kinase 2,MAP kinase 1,MAP kinase 2,MAP kinase isoform p42,Mapk,MAPK 1,MAPK 2,Mapk1,Mitogen-activated protein kinase 1,Mitogen-activated protei 96T
U1206r CLIA Erk2,ERK-2,ERT1,Extracellular signal-regulated kinase 2,MAP kinase 1,MAP kinase 2,MAP kinase isoform p42,Mapk,MAPK 1,MAPK 2,Mapk1,Mitogen-activated protein kinase 1,Mitogen-activated protein kina 96T
U1206m CLIA Erk2,ERK-2,ERT1,Extracellular signal-regulated kinase 2,MAP kinase 1,MAP kinase 2,MAP kinase isoform p42,Mapk,MAPK 1,MAPK 2,Mapk1,Mitogen-activated protein kinase 1,Mitogen-activated protein kina 96T
E1206b ELISA Bos taurus,Bovine,ERK2,ERK-2,ERT1,Extracellular signal-regulated kinase 2,MAP kinase 1,MAP kinase 2,MAPK 1,MAPK 2,MAPK1,Mitogen-activated protein kinase 1,Mitogen-activated protein kinase 2,PRKM 96T
U1206b CLIA Bos taurus,Bovine,ERK2,ERK-2,ERT1,Extracellular signal-regulated kinase 2,MAP kinase 1,MAP kinase 2,MAPK 1,MAPK 2,MAPK1,Mitogen-activated protein kinase 1,Mitogen-activated protein kinase 2,PRKM1 96T
E1206r ELISA Erk2,ERK-2,ERT1,Extracellular signal-regulated kinase 2,MAP kinase 1,MAP kinase 2,MAP kinase isoform p42,Mapk,MAPK 1,MAPK 2,Mapk1,Mitogen-activated protein kinase 1,Mitogen-activated protein kin 96T
E1206m ELISA Erk2,ERK-2,ERT1,Extracellular signal-regulated kinase 2,MAP kinase 1,MAP kinase 2,MAP kinase isoform p42,Mapk,MAPK 1,MAPK 2,Mapk1,Mitogen-activated protein kinase 1,Mitogen-activated protein kin 96T
E1206b ELISA kit Bos taurus,Bovine,ERK2,ERK-2,ERT1,Extracellular signal-regulated kinase 2,MAP kinase 1,MAP kinase 2,MAPK 1,MAPK 2,MAPK1,Mitogen-activated protein kinase 1,Mitogen-activated protein kinase 2 96T
EIAAB24873 CRK1,Crk1,Csbp1,Csbp2,MAP kinase 14,MAP kinase p38 alpha,MAPK 14,Mapk14,Mitogen-activated protein kinase 14,Mitogen-activated protein kinase p38 alpha,Mouse,Mus musculus
EIAAB24970 Leucine zipper- and sterile alpha motif kinase ZAK,Mitogen-activated protein kinase kinase kinase MLT,Mixed lineage kinase-related kinase,MLK-like mitogen-activated protein triple kinase,MLK-related k
E1206h ELISA kit ERK2,ERK-2,ERT1,Extracellular signal-regulated kinase 2,Homo sapiens,Human,MAP kinase 1,MAP kinase 2,MAP kinase isoform p42,MAPK 1,MAPK 2,MAPK1,Mitogen-activated protein kinase 1,Mitogen-ac 96T
U1206h CLIA ERK2,ERK-2,ERT1,Extracellular signal-regulated kinase 2,Homo sapiens,Human,MAP kinase 1,MAP kinase 2,MAP kinase isoform p42,MAPK 1,MAPK 2,MAPK1,Mitogen-activated protein kinase 1,Mitogen-activate 96T
E1206h ELISA ERK2,ERK-2,ERT1,Extracellular signal-regulated kinase 2,Homo sapiens,Human,MAP kinase 1,MAP kinase 2,MAP kinase isoform p42,MAPK 1,MAPK 2,MAPK1,Mitogen-activated protein kinase 1,Mitogen-activat 96T
EIAAB24870 Homo sapiens,Human,MAP kinase 13,MAP kinase p38 delta,MAPK 13,MAPK13,Mitogen-activated protein kinase 13,Mitogen-activated protein kinase p38 delta,PRKM13,SAPK4,Stress-activated protein kinase 4
EIAAB24864 Homo sapiens,Human,MAP kinase 11,MAP kinase p38 beta,MAPK 11,MAPK11,Mitogen-activated protein kinase 11,Mitogen-activated protein kinase p38 beta,p38-2,p38b,PRKM11,SAPK2,Stress-activated protein kinas
EIAAB24875 Canis familiaris,Canis lupus familiaris,CSBP1,CSBP2,Dog,MAP kinase 14,MAP kinase p38 alpha,MAPK 14,MAPK14,Mitogen-activated protein kinase 14,Mitogen-activated protein kinase p38 alpha
EIAAB24858 c-Jun N-terminal kinase 2,Jnk2,MAP kinase 9,MAPK 9,Mapk9,Mitogen-activated protein kinase 9,p54-alpha,Prkm9,Rat,Rattus norvegicus,SAPK-alpha,Stress-activated protein kinase JNK2
EIAAB24867 ERK6,ERK-6,Extracellular signal-regulated kinase 6,Homo sapiens,Human,MAP kinase 12,MAP kinase p38 gamma,MAPK 12,MAPK12,Mitogen-activated protein kinase 12,Mitogen-activated protein kinase p38 gamma,S
EIAAB24866 ERK-6,Extracellular signal-regulated kinase 6,MAP kinase 12,MAP kinase p38 gamma,MAPK 12,Mapk12,Mitogen-activated protein kinase 12,Mitogen-activated protein kinase p38 gamma,Mouse,Mus musculus,Sapk3,
18-662-20087 Mitogen-activated protein kinase 1 - EC 2.7.11.24; Extracellular signal-regulated kinase 2; ERK-2; Mitogen-activated protein kinase 2; MAP kinase 2; MAPK 2; p42-MAPK; ERT1 Polyclonal 0.1 ml
15-288-22768 Mitogen-activated protein kinase 1 - EC 2.7.11.24; Extracellular signal-regulated kinase 2; ERK-2; Mitogen-activated protein kinase 2; MAP kinase 2; MAPK 2; p42-MAPK; ERT1 Polyclonal 0.05 mg
15-288-22768 Mitogen-activated protein kinase 1 - EC 2.7.11.24; Extracellular signal-regulated kinase 2; ERK-2; Mitogen-activated protein kinase 2; MAP kinase 2; MAPK 2; p42-MAPK; ERT1 Polyclonal 0.1 mg
EIAAB24872 MAP kinase 13,MAP kinase p38 delta,MAPK 13,Mapk13,Mitogen-activated protein kinase 13,Mitogen-activated protein kinase p38 delta,Mouse,Mus musculus,Serk4,Stress-activated protein kinase 4


 

GENTAUR Belgium BVBA BE0473327336
Voortstraat 49, 1910 Kampenhout BELGIUM
Tel 0032 16 58 90 45

Fax 0032 16 50 90 45
info@gentaur.com | Gentaur





GENTAUR Ltd.
Howard Frank Turnberry House
1404-1410 High Road
Whetstone London N20 9BH
Tel 020 3393 8531 Fax 020 8445 9411
uk@gentaur.com | Gentaur

 

 




GENTAUR France SARL
9, rue Lagrange, 75005 Paris
Tel 01 43 25 01 50

Fax 01 43 25 01 60
RCS Paris B 484 237 888

SIRET 48423788800017

BNP PARIBAS PARIS PL MAUBERT BIC BNPAFRPPPRG

france@gentaur.com | Gentaur

GENTAUR GmbH
Marienbongard 20
52062 Aachen Deutschland
Support Karolina Elandt
Tel: 0035929830070
Fax: (+49) 241 56 00 47 88

Logistic :0241 40 08 90 86
Bankleitzahl 39050000
IBAN lautet DE8839050000107569353
Handelsregister Aachen HR B 16058
Umsatzsteuer-Identifikationsnummer *** DE 815175831
Steuernummer 201/5961/3925
de@gentaur.com | Gentaur

GENTAUR U.S.A
Genprice Inc, Logistics
547, Yurok Circle
San Jose, CA 95123
CA 95123
Tel (408) 780-0908,
Fax (408) 780-0908,
sales@genprice.com

Genprice Inc, Invoices and accounting
6017 Snell Ave, Ste 357
San Jose, CA 95123




GENTAUR Nederland BV
NL850396268B01 KVK nummer 52327027
Kuiper 1
5521 DG Eersel Nederland
Tel:  0208-080893  Fax: 0497-517897
nl@gentaur.com | Gentaur
IBAN: NL04 RABO 0156 9854 62   SWIFT RABONL2U






GENTAUR Spain
tel:0911876558
spain@gentaur.com | Gentaur






ГЕНТАУЪР БЪЛГАРИЯ
ID # 201 358 931 /BULSTAT
София 1000, ул. "Граф Игнатиев" 53 вх. В, ет. 2
Tel 0035924682280 Fax 0035924808322
e-mail: Sofia@gentaur.com | Gentaur
IBAN: BG11FINV91501014771636
BIC: FINVBGSF

GENTAUR Poland Sp. z o.o.


ul. Grunwaldzka 88/A m.2
81-771 Sopot, Poland
TEL Gdansk 058 710 33 44 FAX  058 710 33 48              

poland@gentaur.com | Gentaur

Other countries

Österreich +43720880899

Canada Montreal +15149077481

Ceská republika Praha +420246019719

Danmark +4569918806

Finland Helsset +358942419041

Magyarország Budapest +3619980547

Ireland Dublin+35316526556

Luxembourg+35220880274

Norge Oslo+4721031366

Sverige Stockholm+46852503438

Schweiz Züri+41435006251

US New York+17185132983

GENTAUR Italy
SRL IVA IT03841300167
Piazza Giacomo Matteotti, 6
24122 Bergamo Tel 02 36 00 65 93
Fax 02 36 00 65 94
italia@gentaur.com | Gentaur